We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of CGC-11047 in Patients With Metastatic Hormone Refractory Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00585416
Recruitment Status : Terminated (Further evaluation of phase I dosing)
First Posted : January 3, 2008
Last Update Posted : October 2, 2015
Sponsor:
Collaborator:
Progen Pharmaceuticals
Information provided by (Responsible Party):
University of Wisconsin, Madison

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : November 2007
  Study Completion Date : March 2009